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Abstract
Background: Delay in diagnosis of pulmonary tuberculosis results in increasing severity, mortality
and transmission. Various investigators have reported about delays in diagnosis of tuberculosis. We
aimed at summarizing the data on these delays in diagnosis of tuberculosis.
Methods: A systematic review of literature was carried out. Literature search was done in Medline
and EMBASE from 1990 to 2008. We used the following search terms: delay, tuberculosis,
diagnosis, and help-seeking/health-seeking behavior without language restrictions. In addition,
indices of four major tuberculosis journals were hand-searched. Subject experts in tuberculosis and
authors of primary studies were contacted. Reference lists, review articles and text book chapters
were also searched. All the studies were assessed for methodological quality. Only studies carried
out on smear/culture-positive tuberculosis patients and reporting about total, patient and health-
care system delays were included.
Results: A total of 419 potential studies were identified by the search. Fifty two studies qualified
for the review. The reported ranges of average (median or mean) total delay, patient delay, health
system delay were 25–185 days, 4.9–162 days and 2–87 days respectively for both low and high
income countries. Average patient delay was similar to health system delay (28.7 versus 25 days).
Both patient delay and health system delay in low income countries (31.7 days and 28.5 days) were
similar to those reported in high income countries (25.8 days and 21.5 days).
Conclusion: The results of this review suggest that there is a need for revising case-finding
strategies. The reported high treatment success rate of directly observed treatment may be
supplemented by measures to shorten the delay in diagnosis. This may result in reduction of
infectious cases and better tuberculosis control.
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Background
Tuberculosis (TB) remains a major global public health
problem [1]. It is estimated that about one-third of the
world's population is infected with Mycobacterium tuber-
culosis [2]. Among the communicable diseases, TB is the
second leading cause of death worldwide, killing nearly
two million people each year [3]. Early diagnosis of the
disease and prompt initiation of treatment are essential
for an effective tuberculosis control program. Delay in the
diagnosis may worsen the disease, increase the risk of
death and enhance tuberculosis transmission in the com-
munity [4].
In developing countries, emphasis is laid on passive case
finding which is based on diagnosing infectious cases of
tuberculosis mainly through direct microscopy of sputum
specimens obtained from persons who present them-
selves to the health facilities [5]. But passive case finding
is known to be influenced by factors such as patient moti-
vation, the degree of diagnostic suspicion by health work-
ers and the quality of laboratory facilities [6]. The directly
observed treatment with short course (DOTS) strategy of
the national TB control programs emphasizes passive case
finding which could result in a delayed diagnosis [7].
These delays may be attributed to both patients as well as
the health care system. The patients may delay in seeking
help or the health care system may delay in suspecting and
investigating for TB. It is important to identify such delays
in order to undertake measures to make the TB control
programs more effective.
Recent studies have shown that health-care seeking behav-
ior of chest symptomatics is inadequate [8] and health
services-related factors have led to sub-optimal utilization
of diagnostic processes [9]. TB control programs of the
high TB burden countries need universal coverage of
DOTS strategy, political commitment and increased case
detection rate [10]. Various studies have reported about
the delays in diagnosis of tuberculosis in different groups
of populations. It is not clear if active case finding would
improve the efficacy of the current global DOTS strategy
[11].
We carried out a systematic review to summarize the evi-
dence from studies reporting time delays in diagnosis of
pulmonary TB among chest symptomatics. The aims of
this review were: 1) to summarize the patient, health-care
system and total delays to diagnosis of pulmonary tuber-
culosis; 2) to compare the delay in diagnosis between low
and middle income countries [LMICs] and high income
countries [HICs].
Methods
Search criteria
We searched the following databases for primary studies:
PubMed (http://www.ncbi.nlm.nih.gov/sites/ent
rez?db=pubmed, from January 1990 to December 2008),
EMBASE (http://www.embase.com/search, from January
1990 to December 2008), HINARI (http://www.who.int/
hinari/en/, from January 1990 to December 2008) and
Cochrane infectious disease group trials register http://
www.update-software.com/clibng/cliblogon.htm. We
used the search terms "delay", "diagnosis", "pulmonary
tuberculosis", and "health care seeking behavior". The
search was done without language restrictions, except for
the condition of an abstract being in English. We also
hand searched the indices of the following journals: Inter-
national Journal of Tuberculosis and Lung Disease; Tuber-
culosis; Tubercle and Lung Disease and BMC Infectious
Diseases. Additional studies were identified by contacting
the authors of the primary studies and experts in tubercu-
losis, by referring to the reports of World Health Organi-
zation (WHO), and by searching the reference lists of
primary studies, review articles, editorials and text book
chapters.
Assessment of the studies
The list of titles and abstracts we identified were screened
independently by two of the authors/reviewers (CTS and
PVK). We included those studies which had reported the
patient, health system and total delay in the diagnosis of
pulmonary tuberculosis made by either sputum/culture
positivity. The selected studies were assessed for method-
ological quality by two of the authors (CTS and PVK). The
reviewers were not blinded to the names of authors of
selected studies.
Exclusion criteria
We excluded studies which described extrapulmonary
tuberculosis only, studies which did not report the delays
in diagnosis separately for pulmonary and extrapulmo-
nary TB, studies assessing health care seeking behavior
only and pure qualitative studies. Although data on
patient, health system and total delays were required, a
few studies which lacked total delay were not excluded: we
summed up the patient and health system delay to obtain
total delay.
Data extraction and analysis
Two reviewers (CTS and PVK) extracted the data from
included studies: duration of patient, health system and
total delay. The duration of delay reported in weeks or
months was transformed in number of days wherever nec-
essary. Additional data consisted of country, survey year,
and type of first contact, type/s of health-care facilities
where the study was carried out (study setting), study
design, and sample size. As time duration does not gener-BMC Infectious Diseases 2009, 9:91 http://www.biomedcentral.com/1471-2334/9/91
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ally follow normal distribution we favoured median dura-
tion, but if median lacked, mean was considered. The
definitions for the delays were not uniform in the
included studies. Most studies used for total delay the
time until the diagnosis, some until treatment. In such a
case we considered the delay until diagnosis as it was
reported by the authors or we calculated delays until diag-
nosis. We categorized the selected studies as those carried
out in LMIC and HIC according to the definition given by
the World Bank. The average of the three types of delays
was calculated from the extracted data according to the
two groups of countries.
Operational definitions
World Bank definitions for LMICs and HICs: World Bank
has classified economies based on gross national income
(GNI) per capita during the year 2007. According to this
the countries are grouped as follows: low income: $935 or
less, low middle income $936 to $ 3705, upper middle
income: $3707 to $ 11,455 and high income: $ 11, 456 or
more. Patient delay was defined as the period from onset
of the first symptom(s) possibly related to pulmonary TB
to the date when the patient first contacted any type
health care service (formal or informal).
Health system delay was defined from the date of the
patient's first contact with the health care service to the
date of diagnosis. Total delay was defined as the sum of
patient delay and health system delay [12]. (Figure 1)
We summarized the average patient, system and total
delays using box-plots, showing medians, interquartile
ranges (25th and 75th percentile), and ranges (minimum
and maximum). We estimated median differences
between low and high income countries in delays,
together with 95% confidence intervals (using the boot-
strap method). Although aim of our study was primarily
descriptive, we tested for differences between low and
high income countries using Wilcoxon's rank-sum tests.
As the outcome of interest was to estimate delay in diag-
nosis, rather than significant effects, publication bias due
to non-significant studies not being published was
unlikely to occur.
Results
Search results
The flow diagram about the results of search and their
inclusion for the review are shown in figure 2. Our search
strategy identified a total of 419 potential studies. Three
hundred and sixty studies reported about health seeking
behavior and/or delays and had an English abstract. Two
hundred and sixty two studies did not provide adequate
information about delays (editorials, comments or case
reports). Of the remaining 98 studies, 50 full-text articles
and two English abstracts corresponded to the inclusion/
exclusion criteria. Reasons for exclusion were qualitative
methodology, inappropriate definition of delays, study of
health care seeking behavior only and extrapulmonary TB.
(Figure 2)
Conceptual framework of the study and definitions of delays (Modified and adapted from Yimer et al) [12] Figure 1
Conceptual framework of the study and definitions of delays (Modified and adapted from Yimer et al) [12]. a = 
patient delay – the time from onset of symptoms to until the patients see the first health care practices. b = health care system 
delay – the time from first health care seeking for diagnosis until the diagnosis made. c = total delay (a + b).BMC Infectious Diseases 2009, 9:91 http://www.biomedcentral.com/1471-2334/9/91
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Out of the 52 retained studies six were retrospective anal-
yses, 12 were longitudinal patient recruitment studies
with structured interview of the patients and 26 studies
were designed as cross-sectional surveys with patient
interviews. For the remaining eight studies, design was
either not clearly stated or mixed methods was used. A
WHO multi-centre study carried out in seven countries of
the eastern Mediterranean region used a cross-sectional
survey design and was considered as one study. Forty six
studies were carried out in LMICs and 10 in HICs. Details
of the studies from LMICs and HICs and their main results
are described in table 1[13-51] and table 2[52-61]. The
summary of delays for diagnosis of pulmonary tuberculo-
sis in LMICs and HICs are shown in figures 3a, b and 3c.
Time delays to diagnosis
The reported average (median or mean) total delay,
patient delay, health system delay for diagnosis of tuber-
culosis were ranging from 25 to185 days, 4.9 to 162 days
and 2 to 87 days respectively in both LMICs and HICs
together. The overall average patient delay was similar to
health system delay (31.03 versus 27.2 days). This was not
different when analysed separately for LMICs and HICs
Search results and selection of studies for systematic review Figure 2
Search results and selection of studies for systematic review.BMC Infectious Diseases 2009, 9:91 http://www.biomedcentral.com/1471-2334/9/91
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Summary† of patient, health care system and total delays in LMIC and HIC Figure 3
Summary† of patient, health care system and total delays in LMIC and HIC. 3. a. Patient Delay. Note: Difference 
in medians (95% confidence interval): 1.5 (-7.5, 12). P-value for Wilcoxon Rank-Sum-Test = 0.637. † Boxplots showing median 
(central line), interquartile range (box) and range (whiskers). 3. b. Health system delay. Note: Difference in medians (95% 
confidence interval): 3.2 (-8.5, 15.3). P-value for Wilcoxon Rank-Sum-Test = 0.684. 3. c. Total delay. Note: Difference in 
medians (95% confidence interval): 8.5 (-2, 25). P-value for Wilcoxon Rank-Sum-Test = 0.204.
A
B
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Table 1: Time delays in diagnosis among pulmonary tuberculosis patients in Low and middle income countries
Year of
Study
Country Study
Design
Study setting Patient
delay
Health system
delay
Total delay Reference
1997 Vietnam Cross-sectional, Interview District TB Units 3 w 7 w 9.9 w [13]
1999 South Africa Cross-sectional, interview Hospitalized patients 4 w 4 w 10 w [14]
1998 Tanzania Cross-sectional, interview Government health facilities 162 d 21 d 185 d [15]
2003 Ethiopia Cross-sectional, interview TB management Units 15 d 61 d 80 d [16]
2002 China Longitudinal recruitment, interview County TB Dispensaries 12.5 d 16 d 25 d [17]
2001 China Cross-sectional, patient records & 
interview
All types of health facilities 12.5 d 2 d 57 d [18]
1997–1998 India Cross-sectional All types of health facilities 20 d 23 d 60 d [19]
1998–2000 Thailand Longitudinal recruitment Tertiary hospital 13.3 d 8.2 d - [20]
1996 Vietnam Cross-sectional, interview Government health facilities 5.8 w 6.1 w 11.9 w [21]
2002 Uganda Cross-sectional, interview TB treatment centres & 
hospitals
1 w 9 w 12 w [22]
2000–2001 Nigeria Longitudinal recruitment, interview Tertiary hospital 8 w 1 w 10 w [23]
2002 Vietnam Cross-sectional, interview District TB units 3 w 1 w 4 w [24]
2004 China Cross-sectional, interview TB dispensaries 30 d 24 d 65 d [25]
2003 India Cross-sectional, TB records and 
interview
DOTS clinics 21 d 7 d 32 d [26]
2003 India Cross-sectional, interview Government health facilities 28 d 28 d 62 d [27]
2003–2004 Thailand Longitudinal recruitment, interview Community and tertiary 
hospital
4.4 w 2.8 w 9.4 w [28]
2001 Ethiopia Cross-sectional, interview Public health centres 60 d 6 d 64 d [29]
1993–1994 Botswana Cross-sectional, TB records & 
interview
TB clinics 3 w 8 w 12 w [30]
1997–1999 Nepal Longitudinal recruitment & 
interview
Government health facilities 0.7 m 1.5 m 2.8 m [31]
1995 Ghana Cross-sectional, interview Chest clinic of a teaching 
hospital
4 w 8 w 12 w [32]
1997 Malaysia Cross-sectional, Interview University Hospital 2 w 7 w 12.5 w [33]
2003–2004 Malaysia Cross-sectional, Interview TB clinics 30 d 22 d - [34]
1999 Turkey Cross-sectional, Interview Hospitalized patients 26.9 13.1 d [35]
2003 Bolivia Cross-sectional, interview TB clinics 3.6 w 6.2 w 12.9 w [36]
1997 Gambia Cross-sectional, interview All types of health centres 0.7 w 10.8 w 11.5 w [37]
2004 Turkey Cross-sectional, interview Tertiary care hospital 46.4 d 30.3 d - [38]
2001 Turkey Cross-sectional, interview Tertiary care hospital 31.4 d 25.4 d - [39]
2006 China Historical cohort, interview - 19 d 5 d 31 d [40]
1994 Malaysia Longitudinal recruitment, interview Tertiary care hospital 15 d 35 d 90 d [41]
1996 Mongolia Cross-sectional, Interview Specialist TB centres 29 d 35 d 78 d [42]
2008 China Retrospective analysis of 
computerized patient records
County TB centres 60 d 4 d 71 d [43]
2008 Argentina Cross-sectional survey, Interview Public health facilities 59 d 33 d 92 d [44]
2007 Bangladesh Cross-sectional survey Public health facilities 50 d 11 d 60 d [45]
2003/4 Pakistan Cross-sectional survey, interview Chest clinics 9 d 87 d 91 d [46]
2003/4 Iran Cross-sectional survey, interview Public health facilities 24 d 42 d 88 d [46]
2003/4 Somalia Cross-sectional survey, interview DOTS centres 53 d 7 d 58 d [46]
2003/4 Egypt Cross-sectional survey, interview Public health facilities 12 d 18 d 42 d [46]
2003/4 Iraq Cross-sectional survey, interview Tertiary care hospital 31 d 2 d 36 d [46]
2003/4 Yemen Cross-sectional survey, interview Public health facilities 28 d 4 d 35 d [46]
2002–2004 Syria Cross-sectional interview DOTS centres 52.7 d 27.6 d 77.6 d [46]
2008 South Africa Cross-sectional, interview Hospital-based 14 30 60 [47]
2003 Syria Prospective recruitment DOTS Clinic 31 12 55 [48]
2005 Kenya Cross-sectional
interview
TB/Chest clinic 42 2 44 [49]
2003 Columbia Cross-sectional
interview
Chest/TB Clinics 30 60 120 [50]
2006 Pakistan Cross-sectional Chest clinic at Teaching 
hospital
33 60 90 [51]BMC Infectious Diseases 2009, 9:91 http://www.biomedcentral.com/1471-2334/9/91
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(p-value 0.506). In HICs the average health system delay
was more than three weeks.
Patient delay
Among the LMICs patient delay varied from 4.9 days in
Gambia [37] to 162 days in Tanzania [15]. The average
patient delay in LMICs was 31.7 days. Among the HICs
patient delay ranged from 7 days in Italy [56] and Taiwan
[53] to 34.5 days in UK [52]. The average patient delay in
HIC was 25.8 days, which is similar to that of LMICs (32.2
days, p-value 0.637). (Figure 3a).
Health care system delay
Among the LMICs health care system delay ranged from
the shortest of 2 days in China [18] to a longest of 87 days
in Pakistan [46]. The average delay was 28.4 days. Among
the HICs health care system delay ranged from a shortest
of 7.2 days in Japan [48] to a longest of 36 days in Italy
[56] with an average delay of 21.5 days. The difference in
average health care system delay between LMICs and HICs
was not statistically different (p-value 0.684). (Figure 3b)
Total delay
Among LMICs the total delay ranged from a shortest of 25
days in China [17] to a longest of 185 days in Tanzania
[15], with an average of 67.8 days. Among the HICs total
delay ranged from a shortest of 42 days in Japan [48] to 89
days in USA [49], with an average of 61.3 days. The differ-
ence in average total delay between LMICs and HICs was
not statistically different (p-value 0.204). (Figure 3c)
Discussion
Main results and comparisons with existing literature
Our systematic review of literature of 52 studies on delays
in diagnosis of tuberculosis showed that there is a consid-
erable time delay between the onset of symptoms of pul-
monary tuberculosis and diagnosis. However comparison
of these (patient, health system and total) delays to diag-
nosis between LMICs and HICs were not significantly dif-
ferent. Another systematic review of the same topic
reported about various patient factors related to delayed
diagnosis of tuberculosis. However this study did not dis-
cuss about the implications of time delays in diagnosis of
TB on its control [62].
Nothing is known about an acceptable time delay from
the onset of symptoms until the diagnosis is made. It is
generally considered that for an effective TB control, the
target for patient delay should not be more than 2 or 3
weeks [63]. Our analysis found that in both LMICs as well
as HICs patient delay far exceeded this limit by about 10–
15 days. As far as health system delay is considered it
should be only a few days. If tuberculosis is suspected spu-
tum test should be requested and processed immediately.
Our analysis found that health system delay was about
four weeks in LMICs and three weeks in HICs. Therefore,
in an ideal world, the total delay to diagnosis should not
be more than 3–4 weeks for most of the smear-positive TB
patients. From our analysis it was observed that this limit
was exceeded by about four weeks in HICs and five weeks
in LMICs.
Weaknesses of our methodology
The studies reported varying time delays. One of the rea-
sons for such variations was the different definitions used
for the first contact with the health system (any type for-
mal or informal). For our analysis we used contact with
any type of health system. This resulted in wide disparities
in the patient delay and health system delays from studies
carried out in different countries. For example in Gambia
there was yawning gap between the patient delay (5 days)
and health system delay (76 days) as this study considered
contact with traditional healer for the estimation of health
system delay [37].
Despite carrying out a comprehensive search some studies
may have been missed to be included for this systematic
review. We did not carry out a sub group analysis to
decrease the heterogeneity between various studies. Since
we excluded non-English abstracts we may have missed
Table 2: Time delays (in days) in diagnosis among pulmonary tuberculosis patients in High income countries
Year of
Study
Country Study
Design
Study setting Patient
delay
Health system
delay
Total delay Reference
1992 Korea Longitudinal Recruitment Health centres 54 d 14 d 60 d [52]
1997 Japan Longitudinal recruitment, interview Tertiary hospital 21 d 7.2 d 42 d [53]
2000–2001 USA Longitudinal recruitment, interview Tertiary care hospital 32 d 26 d 89 d [54]
1994 USA Longitudinal recruitment, interview All types of health facilities 25 d 15 d 57 d [55]
2003–2004 Norway Retrospective analysis National TB registry 28 d 33 d 63 d [56]
2001–2002 UK Retrospective analysis TB register 34.5 d 29.5 d 78 d [57]
2003 Taiwan Cross-sectional, interview National TB register 7 d 23 d 44 d [58]
2004 Hong Kong Longitudinal recruitment, Interview TB units 20 d 20 d 49 d [59]
1985–1998 Australia Retrospective analysis TB registry 30 d 11 d 66 d [60]
2003 Italy Retrospective analysis Disease surveillance data 7 d 36 d 65 d [61]BMC Infectious Diseases 2009, 9:91 http://www.biomedcentral.com/1471-2334/9/91
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some non-English full-text articles. If studies which did
not find a longer time delays in diagnosis may not have
been published which would have resulted in publication
bias. Some studies reported mean delay instead of median
delay, which may have resulted in difficulties in estimat-
ing the average time delay to diagnosis in our analysis.
Impact of our results
The delays have importance in transmission dynamics of
tuberculosis and TB prevention and control strategies,
hence also on the current global strategy for tuberculosis
control. It has been reported that the global DOTS strategy
for TB has improved the overall treatment success rate [7].
However, rapid geographic coverage by DOTS has not
resulted in improved case finding [64]. There are further
reports that current case detection rates are low and there
is a need for developing new case finding strategies to
reach the targets under global DOTS strategy [65]. A study
from India has reported that improving the case finding
methods may save 10 times more patients than by the
DOTS [66]. The time delays to diagnosis identified by this
review confirm these suggestions. A recent analysis of TB
transmission dynamics and delay has stressed that time
delays to diagnosis are the most important obstacles to
the control of the TB epidemic [67]. It is important to
investigate the causes of such delays to diagnosis. Most
studies have reported about the patient factors responsi-
ble for the delay and have suggested improvement of
patient knowledge/awareness [63]. Another review has
concluded that the crux of the problem is the repeated vis-
its to a healthcare provider for diagnosis at the same level
of the healthcare system [62]. The health system may be
failing to suspect and diagnose TB early enough to reduce
the delay in diagnosis. From our analysis it is clear that
both patient and the health system are to blame as both
patient and health care system delays were longer than
acceptable limits.
Future research
Our understanding of the health system factors responsi-
ble for the time delay in diagnosis is limited. Further
research is needed to analyze the health system factors
responsible for delay in diagnosis of TB. It has been sug-
gested that active case finding strategies (in target groups,
symptom screening, house-to-house case search, and con-
tact investigation) rather than just passive case finding
may be helpful to reduce the delays in diagnosis [68]. It
may also be important to choose appropriate case finding
strategies based on the epidemiological situation of TB in
a particular country.
Conclusion
This review suggests that there is an unacceptable time
delay before the diagnosis of pulmonary tuberculosis is
made. There is a need to revise the current case finding
strategies under the DOTS strategy adopted world wide.
The reported high treatment success rate of directly
observed treatment may be supported by measures to
shorten the delay in diagnosis. This may result in reduc-
tion in transmission and in better tuberculosis control.
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